Singular Genomics to Present at Cowen’s 43rd Annual Health Care Conference

SAN DIEGO, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced plans to present at Cowen’s 43rd Annual Health Care Conference in Boston, Massachusetts.

Singular Genomics’ management is scheduled to participate in a fireside chat Tuesday, March 7, 2023, at 8:10 a.m. Pacific Time / 11:10 a.m. Eastern Time. Investors and other interested parties are invited to listen to a live and recorded webcast of the presentation at investor.singulargenomics.com, in the News & Events section.

About Singular Genomics Systems, Inc.

Singular Genomics is a life science technology company that develops next-generation sequencing and multiomics technologies. The commercially available G4 Sequencing Platform is a powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate results. In development, the PX system leverages Singular’s proprietary sequencing technology, applying it as an in-situ readout to look at RNA and proteins in single cells and tissue. With these products, Singular Genomics’ mission is to empower researchers and clinicians to advance science and medicine. Visit www.singulargenomics.com for more information.

Investor Contact

Matt Clawson949-370-8500[email protected]

Media Contact

Dan Budwick, 1AB973-271-6085[email protected]

Source: Singular Genomics Systems, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Nicholas Abaza Named to Htown Best as a Top Probate Lawyer in Houston
• Shanghai Electric Secures First Overseas Heavy-Duty Gas Turbine Order for 500 MW Malaysian Project
• Corgan Expands Aviation Practice in Asia Pacific with Ben Dawson Hire